![](/img/cover-not-exists.png)
Multicenter 1-year trial on formoterol, a new long-actingβ2-agonist, in chronic obstructive airway disease
G. Schultze-WerninghausVolume:
168
Language:
english
Pages:
7
DOI:
10.1007/bf02718118
Date:
December, 1990
File:
PDF, 393 KB
english, 1990